[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EP0000106B1 - 2-Alkyl-nicotinoides, leurs procédés de préparation et leur utilisation - Google Patents

2-Alkyl-nicotinoides, leurs procédés de préparation et leur utilisation Download PDF

Info

Publication number
EP0000106B1
EP0000106B1 EP78300040A EP78300040A EP0000106B1 EP 0000106 B1 EP0000106 B1 EP 0000106B1 EP 78300040 A EP78300040 A EP 78300040A EP 78300040 A EP78300040 A EP 78300040A EP 0000106 B1 EP0000106 B1 EP 0000106B1
Authority
EP
European Patent Office
Prior art keywords
methyl
compound according
formula
compound
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
EP78300040A
Other languages
German (de)
English (en)
Other versions
EP0000106A1 (fr
Inventor
Edward Barkev Sanders
Henry Valette Secor
Jeffrey Ira Seeman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Philip Morris USA Inc
Original Assignee
Philip Morris USA Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philip Morris USA Inc filed Critical Philip Morris USA Inc
Publication of EP0000106A1 publication Critical patent/EP0000106A1/fr
Application granted granted Critical
Publication of EP0000106B1 publication Critical patent/EP0000106B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57—Nitriles

Definitions

  • the present invention relates to a group of novel nicotine analogues containing alkyl substituents ortho to the pyrrolidine ring.
  • the synthetic procedures disclosed herein for the production of nicotine analogues constitute considerably shorter and more practical routes than those previously proposed.
  • the novel compounds produced by the methods of the present invention are useful as insecticides.
  • Nicotine has been used as an insecticide for many years (see, for example, D. E. H. Frear, "Chemistry of the Pesticides," 3rd Ed., D. Van Nostrand Co., New York, 1955). Although a number of natural as well as synthetic nicotinoids have been screened with regard to insecticidal activity, the vast majority are significantly less active than nicotine [see J. Yamamoto et al., Agr. Biol. Chem. 32, 1341 (1968)]. The analogues of nicotine which have been tested involve either the alteration of the pyrrolidine moiety of the molecule, or the replacement of the pyridine ring with a substituted aromatic ring.
  • the paper describes a new synthetic process for the production of 2-alkyl-3-acylpyridines and 2-alkyl-3-formylpyridines via [2,3]-sigmatropic rearrangement of 1-cyanomethyl-1-( ⁇ -alkyl-2-picolyl) pyrrolidinium salts.
  • the versatility of this procedure is evidenced by the fact that the a-cyanoamine initially obtained can be hydrolyzed to an aldehyde, reductively cleaved to an amine, or alkylated and hydrolyzed to a ketone.
  • the present invention concerns new and improved processes for the production of compounds represented by the formula: wherein R, is hydrogen, lower alkyl, phenyl, alkaryl or phenylalkyl, R 2 is lower alkyl or phenylalkyl, and R 3 is a heterocyclic group represented by the formula: wherein R 4 is hydrogen or lower alkyl, R s is lower alkyl, and n is one or two.
  • the invention also includes the resulting compounds of this formula, except that in the case of 2-methylnicotine it extends only to the isolated, substantially pure compound.
  • the present invention may make use of novel intermediate products, some of which are useful in the production of compounds of Formula I and are represented by the formula: wherein R 1 and R 2 are the same as defined in Formula I and R 6 is represented by the formula: wherein R 7 is hydrogen, lower alkyl, ⁇ -cyanoalkyl or phenylalkyl, and each R 8 is independently selected from lower alkyl or when taken together with a connecting element, a heterocyclic structure is formed.
  • R 7 is hydrogen, lower alkyl, ⁇ -cyanoalkyl or phenylalkyl
  • each R 8 is independently selected from lower alkyl or when taken together with a connecting element, a heterocyclic structure is formed.
  • the intermediates are readily prepared by the method depicted in Scheme II hereinbelow.
  • lower alkyl means straight-chain or branched alkyl groups with 1 to 6 carbon atoms, for example methyl, ethyl, propyl, isopropyl, butyl, and the like, with methyl being preferred.
  • Alkaryl means aromatic radicals containing between 7 and 10 carbon atoms such as tolyl or xylyl.
  • Phenylalkyl includes radicals such as benzyl, phenylethyl or phenylpropyl.
  • Heterocyclic structures are meant to include cyclic amines such as pyrrolidine, morpholine, pyridine or tetrahydropyridines.
  • the compounds within the scope of the Formula I have two basic nitrogen atoms and can therefore form acid addition salts with inorganic and organic acids; for example, hydrochloric acid, acetic acid, maleic acid, p-toluenesulfonic acid or ethanesulfonic acid.
  • the salts of the compounds within the scope of Formula I can also be in the form of hydrates, for example, mono, tri- or polyhydrate.
  • the compounds of Formula I may be synthesized by two different but related processes.
  • a 2-halomethyl or substituted methylpyridine represented by the formula: wherein R 1 is the same as defined in Formula I, R 2 , is hydrogen, C 1-5 alkyl, phenyl or phenylalkyl and X is halogen, such as bromine, chlorine, iodine, or fluorine, with bromine being preferred, is reacted with a 2-cyano-N-substituted heterocyclic of the formula: wherein R 4 and R 5 are lower alkyl and n is one or two, to give a 1-alkyl-1-(2-picolyl or 2-a-alkylpicolyl)-2-cyanopyrrolidinium halide or the corresponding 1,2,3,6-tetrahydropyridinium halide.
  • the 2-haloalkylpyridine starting materials are readily available or may be synthesized by known methods.
  • the 1-alkyl-2-cyanopyrrolidines are prepared by treatment of a 1-alkyl-2-pyrrolidinone with a reducing agent such as sodium aluminum hydride followed by reaction with ammonium cyanide.
  • the 2 cyano-N-substituted 1,2,3,6-tetrahydropyridines are prepared according to methods described in J. Org. Chem., 29, 1647 (1964).
  • the reaction is carried out by adding a 2-haloalkylpyridine to a 1-alkyl-2-cyanopyrrolidine dissolved in an aprotic polar solvent such as dimethylsulfoxide, acetonitrile, etc.
  • an aprotic polar solvent such as dimethylsulfoxide, acetonitrile, etc.
  • the reaction is allowed to continue until salt formation is complete as determined by, for example, thin layer chromatography.
  • the [2,3]-rearrangement (Schemes I, below) of the pyrrolidine moiety is achieved by diluting the product (VII) obtained above with an aprotic solvent such as tetrahydrofuran, dimethylsulfoxide, hexamethylphosphoric triamide, acetonitrile, and the like, with tetrahydrofuran being preferred, and then adding a strong nonnucleophilic base such as potassium-tert-butoxide, potassium hydride, sodium hydride, sodium amide, and the like. After an appropriate reaction time of about 4 to about 8 hours, the product is isolated by standard extraction techniques known in the art.
  • an aprotic solvent such as tetrahydrofuran, dimethylsulfoxide, hexamethylphosphoric triamide, acetonitrile, and the like
  • a strong nonnucleophilic base such as potassium-tert-butoxide, potassium hydride, sodium hydride, sodium amide, and the like.
  • the reaction can be carried out using a base such as sodium amide and liquid ammonia as the solvent.
  • a base such as sodium amide and liquid ammonia as the solvent.
  • the latter method minimizes formation of side products which occur in certain examples.
  • the crude 2-alkyl-2'-cyano- nicotine product (VIII) isolated by standard techniques is then treated with a reducing agent such as lithium aluminum hydride, sodium borohydride, sodium cyanohydride and the like. Heating may be required to complete the reaction and the crude product is then isolated and may be further purified by standard techniques to yield the desired 2-alkylnicotinoids of Formula IX: wherein R 1 and n are the same as defined in Formulae I and II, R 2 is hydrogen, C 1-5 alkyl, phenyl or phenylalkyl and R 4 is lower alkyl.
  • a 2-alkyl-3-(1-cyano-1-pyrrolidinylmethyl)pyridine (XIV) is generally not isolated, but its formation may be confirmed by pmr spectroscopy.
  • the compounds of Formula XIV may then be treated with one equivalent of a strong base, followed by alkylation with a haloalkylnitrile, and acid hydrolysis to give a 2-methyl-3 pyridyl cyanoalkyl ketone of Formula XV.
  • the ketone thus formed may be cyclized under reducing conditions to yield compounds of Formula (XVI).
  • the reduction can be carried out catalytically, by means of noble metal catalyst, for example, by means of platinum, or by means of Raney nickel catalyst under elevated pressure, for example, under a pressure of more than 2 atmospheres.
  • the compounds of Formula I obtained in the manner described above are unsubstituted at the nitrogen, i.e. R 4 is hydrogen.
  • the a-cyanoamine resulting from the rearrangement may be reduced to the corresponding amine or treated with an organometallic reagent to form an alkylated amine.
  • R 2 of Formula I is an alkyl group other than methyl, for example, ethyl or propyl
  • the compound may be prepared by starting with the appropriate 2-a-alkylpicoline as previously described herein above (Scheme I and Scheme II), or in an alternate approach by further alkylation of R 2 .
  • 2-methylnicotine may be readily converted to 2-ethylnicotine by treatment with phenyllithium followed by alkylation with a haloalkyl such as metholiodide.
  • 2-methylnicotine may be converted to a 2-phenylalkylnicotine by treatment with phenyllithium and alkylation with a haloalkylphenyl moiety to yield a compound of Formula I, such as, for example, 2-phenylethyInicotine.
  • the reaction mixture was cooled and the organic and aqueous phase separated.
  • the aqueous phase was washed with 100 ml of ether.
  • the ether and tetrahydrofuran phases were then combined and washed with two 100 ml portions of a saturated sodium chloride solution.
  • the organic phase was dried over sodium sulfate and filtered preparatory to removal of solvent under reduced pressure.
  • the residue was distilled to yield 10.0 g of 1-methyl-2-cyanopyrrolidine.
  • the compound had a boiling point of 57-9° at 9.5 mm of Hg.
  • the resulting oil was dissolved in 100 ml dimethylsulfoxide and 500 ml tetrahydrofuran and then cooled to -10°. To the solution was added 4.5 g (94 mmol) 50% sodium hydride dispersion. The reaction was stirred for 3.5 hours at 0° and 16 hours at room temperature. The reaction mixture was filtered and the solvent was removed under reduced pressure giving a tan oil containing some solid material. The oil was dissolved in a small amount of ether and the solution filtered to remove insolubles. The ether solution was washed three times with a basic saturated sodium chloride solution, dried over sodium sulfate, filtered and concentrated to give 14.96 g of an oil.
  • the oil was dissolved in 300 ml 95% ethanol and 4.7 g (124 mmol) of sodium borohydride was added. The mixture was stirred at 0° for 1 hour and at room temperature for 2 hours. The reaction mixture was filtered and the precipitate was washed first with ethanol and then with ether. The filtrate was concentrated, taken up in ether and filtered to remove additional insolubles. The filtrate was extracted with three 20 ml portions of 20% acetic acid. The combined acid extracts were washed with ether, diluted with 11.3 ml of concentrated hydrochloric acid and concentrated to dryness. The residue was treated with 50% aqueous potassium hydroxide and extracted with three portions of ether. The ether extracts were combined and dried over sodium sulfate.
  • the solution was concentrated to about 15 ml after which 30 ml dimethyl sulfoxide was added, and the reaction mixture was stirred for 21 hours.
  • the solution was continuously extracted with ether and the ether insoluble residue was dissolved in methanol, transferred to a 500 ml three-necked flask, and evaporated in vacuo to dryness to give 7.33 g (79%) of a dark red semi-solid.
  • Two hundred fifty ml of liquid ammonia was condensed into the flask and 1.23 g (31.4 mmol) of sodium amide was added. The reaction mixture was stirred at -60° for 30 minutes and then at reflux for 2 hours.
  • the ammonia was allowed to boil off leaving a brown residue which was triturated with ether and the resulting ether solution was filtered, and concentrated to give 2.71 g of a brown oil.
  • the oil was dissolved in 125 ml of 95% ethanol and 2.0 g of sodium borohydride was added. After stirring at room temperature for 8 hours, the ethanol was removed and the residue was dissolved in ether.
  • the etheral solution was extracted with 5% hydrochloric acid, the acid solution was washed with ether, basified with aqueous potassium hydroxide, and extracted with ether. The ether extracts of the basic solution were combined, dried over magnesium sulfate, filtered, and the solvent was removed.
  • 2-methylnicotine is treated with phenyllithium as in Example 6.
  • phenyllithium is added to the resulting anion.
  • the product can be isolated by distillation.
  • 2-bromomethyl-6-methylpyridine is treated with dimethylamine to give the corresponding tertiary amine, 2-dimethylaminomethyl-6-methylpyridine.
  • the tertiary amine is treated with cyanomethyl benzenesulfonate, as in Preparation II, to give dimethylcyanomethyl-(6-methyl-2-picolyl) ammonium benzene sulfonate,
  • the quaternary ammonium salt is rearranged using sodium hydride and alkylated with benzylbromide according to the procedure described in Preparation III.
  • the alkylated cyanoamine is decyanated with sodium borohydride in ethanol to give the desired product which can be purified through its picrate.
  • a 100 mg sample of the candidate compound was dissolved in 10 ml absolute ethanol. To the solution was added 40 ml tap water containing 0.5 ml of 1% surfactant. A 5 ml sample of each solution was sprayed on to replicate ivy cuttings infested with Aphids, The results, tabulated below in Table 1 were recorded 18 hours following the application of the sprays.
  • mice LD 50 of the compounds in mice is a measure of their mammalian toxicity.
  • the second column illustrates the effectiveness of the candidate compounds as insecticides as compared to nicotine, whereas the third column is the ratio of insecticidal effectiveness to mammalian toxicity. This ratio shows that the alkylated nicotines are more effective insecticides than nicotine in that they are considerably safer with regard to mammalian response.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Claims (16)

1. Une composé représenté par la formule:
Figure imgb0039
où R1 est l'hydrogène, un alcoyle inférieur (tel que défini ci-dessous), du phénylalcoyle, du phényle ou de l'alcaryle (tel que défini ci-dessous), R2 est un alcoyle inférieur (tel que défini ci-dessous) ou du phénylalcoyle, et R3 est hétérocyclique et est représenté par la formule:
Figure imgb0040
où R4 est de l'hydrogène, un alcoyle inférieur (tel que défini ci-dessous), Rs est un alcoyle inférieur (tel que défini ci-dessous) et n est égal à un ou deux, mais à l'exception de la 2-méthylnicotine; ou un sel d'addition acide ou un hydrate de celui-ci; on considère ici comme "alcoyle inférieur" un groupe alcoyle à chaîne droite ou branchée comportant de 1 à 6 atomes de carbone et comme "alcaryle" un radical aromatique contenant de 7 à 10 atomes de carbone.
2. Un composé conforme à la revendication 1 où R2 est du méthyle ou de l'éthyle.
3. Un composé conforme à la revendication 1 ou 2 où R3 est du N-méthyl-2-pyrrolidinyle.
4. La 2-méthylnicotine dans un état isolé et essentiellement pur.
5. Un composé conforme à la revendication 1 où R3 est du 1,2,3,6-tétrahydro-2-pyridyle.
6. Un composé conforme à la revendication 1 qui est de la 2-éthyl-3-(1-méthyl-2-pyrrilidinyle)-pyridine.
7. Un composé conforme à la revendication 1 qui est de la 2-méthyl-ou 2-éthyl-3-(2-pyrrolidinyle) pyridine.
8. Un composé conforme à la revendication 1 qui est de la 2,6-diméthyl-3-(1-méthyl-2-pyrroli- dinyle) pyridine.
9. Un composé conforme à la revendication 1 qui est de la 2-méthyl-3-(2-piperidinyle) pyridine.
10. Un composé conforme à la revendication 1 qui est de la 2-méthyl-3-(1-methyl-2-(1,2,3,6-tétrahydropyridinyle))-pyridine.
11. Un procédé pour la préparation d'un composé conforme à la revendication 1, caractérisé par:
(a) la réaction d'un composé de la formule:
Figure imgb0041
où R1 est comme défini dans la revendication 1, R2 est de l'hydrogène, un alcoyle inférieur (étant un groupe alcoyle à chaîne droite ou branchée comportant de 1 à 5 atomes de carbone), du phényle ou du phénylalcoyle, X est du chlore, du brome, de l'iode, ou du fluor, avec un composé hétérocyclique 2-cyano-N-substitué de la formule:
Figure imgb0042
où R4 est un alcoyle inférieur (tel que défini ci-dessus) et R5 et n sont comme définis dans la revendication 1, pour obtenir un composé de réaction de la formule:
Figure imgb0043
(b) traitement du produit du point (a) avec une base fortement non-nucléophilique pour obtenir un produit à réarrangement (2,3) de la formule:
Figure imgb0044
où R1, R2, R4, R5 et n sont indentiques a la définition du point (a),
(c) le traitement du produit du point (b) avec un agent de réduction mélangé à de l'hydrure pour décyaniser le composé et isoler le produit.
12. Un procédé conforme à la revendication 11, caractérisé par le fait que la base forte est du butoxyde tertiaire de potassium, de l'hydrure de sodium, de l'hydrure de potassium ou de l'amidure de sodium.
13. Un procédé conforme à la revendication 11 ou 12, où l'agent réducteur est sélectionné à partir du borohydrure de sodium, de l'hydrure de lithium aluminium, ou de cyanohydrure de sodium.
14. Un procédé conforme à la revendication 11, 12, ou 13 où les point (a) et (b) ont été réalisés en présence d'un solvant aprotique.
15. L'utilisation d'un composé conforme à l'une des revendications 1 à 10 comme insecticide.
16. Une composition insecticide contenant comme ingrédient actif un composé conforme à l'une des revendications 1 à 10 conjointement avec un support ou un véhicule de celui-ci.
EP78300040A 1977-06-13 1978-06-13 2-Alkyl-nicotinoides, leurs procédés de préparation et leur utilisation Expired EP0000106B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US05/805,689 US4155909A (en) 1977-06-13 1977-06-13 2-Alkyl nicotinoids and processes for their production
US805689 1977-06-13
US05/972,161 US4220781A (en) 1977-06-13 1978-12-21 Process for preparing 2-alkyl nicotinoids

Publications (2)

Publication Number Publication Date
EP0000106A1 EP0000106A1 (fr) 1978-12-20
EP0000106B1 true EP0000106B1 (fr) 1982-02-17

Family

ID=27122812

Family Applications (1)

Application Number Title Priority Date Filing Date
EP78300040A Expired EP0000106B1 (fr) 1977-06-13 1978-06-13 2-Alkyl-nicotinoides, leurs procédés de préparation et leur utilisation

Country Status (3)

Country Link
US (2) US4155909A (fr)
EP (1) EP0000106B1 (fr)
DE (1) DE2759198A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321387A (en) * 1980-03-21 1982-03-23 Philip Morris, Incorporated Process for the preparation of optically active nicotine analogs
US4332945A (en) * 1981-01-29 1982-06-01 Philip Morris, Incorporated Optically active nicotine analogs and process for their preparation
US5015741A (en) * 1989-10-03 1991-05-14 Philip Morris Incorporated Nicotine analogs
DE69231658T2 (de) * 1991-03-01 2001-09-06 University Of Florida Research Foundation, Inc. Verwendung von nikotinanalogen zur behandlung von degenerativen erkrankungen des nervensystems
EP0659078B1 (fr) * 1992-08-31 2003-01-15 University Of Florida Research Foundation, Inc. Derives d'anabaseine utilises dans le traitement de troubles degeneratifs du systeme nerveux
US5977144A (en) * 1992-08-31 1999-11-02 University Of Florida Methods of use and compositions for benzylidene- and cinnamylidene-anabaseines
US5703100A (en) * 1994-11-10 1997-12-30 Sibia Neurosciences, Inc. Modulators of acetylcholine receptors
US5723477A (en) * 1994-11-10 1998-03-03 Sibia Neurosciences, Inc. Modulators of acetylcholine receptors
US5677459A (en) * 1994-11-10 1997-10-14 Sibia Neurosciences, Inc. Methods for the preparation of modulators of acetylcholine receptors
US5705512A (en) * 1994-11-10 1998-01-06 Sibia Neurosciences, Inc. Modulators of acetylcholine receptors
US5594011A (en) * 1994-11-10 1997-01-14 Sibia Neurosciences, Inc. Modulators of acetylcholine receptors
US6194581B1 (en) 1995-04-07 2001-02-27 Merck & Co., Inc. Substituted pyridines useful as modulators of acetylcholine receptors
US5794887A (en) 1995-11-17 1998-08-18 Komerath; Narayanan M. Stagnation point vortex controller
AU2290800A (en) * 1999-01-14 2000-08-01 Lonza A.G. 1-(6- methylpyridine- 3-yl)-2-(4- (methylsulfonyl) phenyl) ethanone and method for its preparation
KR100446324B1 (ko) * 1999-01-14 2004-08-30 론자 아게 1-(6-메틸피리딘-3-일)-2-[4-(메틸술포닐)페닐]에타논 및이의 제조 방법
SE0000933D0 (sv) * 2000-03-21 2000-03-21 Independent Pharmaceutica Ab Method of producing 6-substituted (S)-nicotine derivatives and intermediate compounds
TWI335332B (en) * 2001-10-12 2011-01-01 Theravance Inc Cross-linked vancomycin-cephalosporin antibiotics
US8557804B2 (en) 2002-03-25 2013-10-15 Universite Laval Nicotinic receptor agonists for the treatment of inflammatory diseases
US8039459B2 (en) * 2004-07-15 2011-10-18 Universite Laval Nicotinic receptor agonists for the treatment of inflammatory diseases
CN116250483B (zh) 2015-06-26 2024-01-30 奥驰亚客户服务公司 用于生产烟草植物的组合物和方法以及具有改变的生物碱含量的制品
GB201515921D0 (en) * 2015-09-08 2015-10-21 Parker Hannifin Mfg Uk Ltd Method
US10897925B2 (en) 2018-07-27 2021-01-26 Joseph Pandolfino Articles and formulations for smoking products and vaporizers
US20200035118A1 (en) 2018-07-27 2020-01-30 Joseph Pandolfino Methods and products to facilitate smokers switching to a tobacco heating product or e-cigarettes

Also Published As

Publication number Publication date
US4220781A (en) 1980-09-02
US4155909A (en) 1979-05-22
EP0000106A1 (fr) 1978-12-20
DE2759198A1 (de) 1978-12-21

Similar Documents

Publication Publication Date Title
EP0000106B1 (fr) 2-Alkyl-nicotinoides, leurs procédés de préparation et leur utilisation
US4115400A (en) 1-Azoniabicyclo[3.1.0]hexanes
Hoffman et al. Synthesis and evaluation of 2-pyridinone derivatives as HIV-1-specific reverse transcriptase inhibitors. 4. 3-[2-(Benzoxazol-2-yl) ethyl]-5-ethyl-6-methylpyridin-2 (1H)-one and analogs
Taylor et al. A general method of alkylation and alkenylation heterocycles
US4081450A (en) 1,3,4-Trisubstituted-4-arylpiperidines and their preparation
US4191771A (en) Analgesic method using 1,3,4-trisubstituted-4-arylpiperidines
Sundberg et al. Lithiation of methoxyindoles
US5112826A (en) Vasodilatory dihydrodibenzocycloheptyliden-ethylpiperazine derivatives
CS183391A3 (en) Process for preparing dialkylpyridine-2,3-dicarboxylates and derivatives thereof
Adamson et al. 212. Aminoalkyl tertiary carbinols and derived products. Part III. 3-Tertiary-amino-1-aryl-1-(2-pyridyl)-propan-1-ols and-prop-1-enes
US3976660A (en) Pyrrolidine derivatives
Crook et al. Piperidine Derivatives X. The Phenylpiperidylcarbinols
US4797496A (en) Process for the preparation of pyrrolidone derivatives
FR2557570A1 (fr) Nouveaux derives de la quinoleine, leur procede de preparation et les compositions pharmaceutiques les renfermant
CH617934A5 (fr)
US4758577A (en) 4-(5H-dibenzo[a,d]cyclohepten-5-yl)piperidine compounds for treating cardiovascular disorders
US4167638A (en) Process for production of 8-NHR quinolines
Beyerman et al. Synthetic neuromuscular‐and ganglion‐blocking agents. N‐Alkylated bipyridyls, bipiperidyls, and their methylene and ethylene “homologues”
US4251659A (en) Polyfluorohydroxyisopropyl-heterocyclic compounds
US5380858A (en) Process for the preparation of intermediates useful for the synthesis of histamine receptor antagonists
HU183612B (en) Process for producing new 4-quinoline-methan derivatives
JPH0154341B2 (fr)
JPS6257631B2 (fr)
US4436740A (en) 3-Cycloalkylamino-2-OR-propoxycyanopyridines
US4656179A (en) Isoquinoline derivatives, and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): CH FR GB

17P Request for examination filed
GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): CH FR GB

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 19830622

Year of fee payment: 6

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 19830711

Year of fee payment: 6

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Effective date: 19840630

GBPC Gb: european patent ceased through non-payment of renewal fee
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19850228

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Effective date: 19881117

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT